Atlas Trials

The Effect of Atorvastatin 80 mg on Hs-CRP/Albumin Ratio in Reducing Thrombus Burden in PCI-STEMI Patients

Clinical trial NCT06871358 · COMPLETED

Trial details

NCT number
NCT06871358
Sponsor
Universitas Sebelas Maret
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
STEMI (STE-ACS)Primary PCI for STEMI
Start date
2024-09-01
Primary completion
2024-10-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.